Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Novartis Presents New Data from Large European Study of Tasigna

June 15, 2015 3:37 pm | News | Comments

The final results of this large study, conducted in 26 European countries, were presented at the 20th Congress of the European Hematology Association (EHA) in Vienna. Read more...

TOPICS:

Actavis Begins Operating as Allergan

June 15, 2015 3:10 pm | News | Comments

Allergan has initiated a rebranding campaign that will guide the transition of its facilities, operations and commercial presence around the world to the new company name. Read more...

TOPICS:

Battling Brain Tumors

June 15, 2015 2:54 pm | by Washington University in St. Louis | News | Comments

The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells. Read more...

TOPICS:
Advertisement

Dementia Drug Developer Axovant Climbs after $315M IPO

June 15, 2015 2:49 pm | by The Associated Press | News | Comments

Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected. Read more...

TOPICS:

Mass. Prisoners Sue to Get Hepatitis Treatment

June 15, 2015 12:19 pm | by Seth Augenstein, Digital Reporter | News | Comments

Two prisoners have sued the Massachusetts Department of Corrections to get access to the latest hepatitis treatments. The two inmates, Emilian Paszko and Jeffrey Fowler, argue that the prison system has been withholding treatment from the estimated 1,500 patients in the Massachusetts state prison system who have hepatitis C. Read more...

TOPICS:

Vulnerabilities in Genome’s ‘Dimmer Switches’ Should Shed Light on Hundreds of Complex Diseases

June 15, 2015 10:33 am | by Johns Hopkins University | News | Comments

Up to one-fifth of human DNA act as dimmer switches for nearby genes, but scientists have long been unable to identify precisely which mutations in these genetic control regions really matter in causing common diseases. Now, a decade of work at Johns Hopkins has yielded a computer formula that predicts with far more accuracy than current methods. Read more...

TOPICS:

Ventana Receives FDA Approval for Lung Cancer Diagnostic

June 15, 2015 10:23 am | News | Comments

Ventana Medical Systems, Inc.  (Ventana), a member of the Roche Group, today announced approval of the VENTANA ALK (D5F3) CDx Assay by the US Food and Drug Administration (FDA) as a companion diagnostic to aid in the identification of patients for Pfizer's FDA approved targeted therapy, Xalkori (crizotinib). Read more...

TOPICS:

Majority of Adults Favor Ban on Powdered Alcohol

June 15, 2015 10:08 am | by University of Michigan | News | Comments

After this year's legalization of powdered alcohol, some states have already banned it—a move that the majority of the public supports, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. Read more..

TOPICS:
Advertisement

FDA Approves Brain Implant to Help Reduce Parkinson's Disease, Tremor Symptoms

June 15, 2015 10:01 am | News | Comments

The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. Read more...

TOPICS:

Target Selling Pharmacy, Clinic Businesses to CVS Health

June 15, 2015 9:47 am | by Tom Murphy, AP Business Writer | News | Comments

Target will sell its pharmacy and clinic businesses to the drugstore chain CVS Health for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations. Read more....

TOPICS:

Mini-Breast Grown in Petri Dishes: New Tool for Cancer Research

June 15, 2015 8:48 am | by Helmholtz Zentrum Munchen | News | Comments

To elucidate how aggressive types of breast cancer occur, the researchers first examined the function of normal breast stem cells. Read more...

TOPICS:

Axial Spondyloarthritis Treatment Market Value Will Almost Double to $2.9B by 2024

June 15, 2015 8:33 am | by Heather Leach, Ph.D., Immunology Analyst, GlobalData | Articles | Comments

The company’s latest report states that the US will cement its position as the largest of the seven major treatment markets (7MM) for axSpA. Read more...

TOPICS:

LDC, J&J Innovation to Collaborate on Acceleration of Academic Drug Discovery Initiatives

June 15, 2015 8:22 am | News | Comments

Both companies will collaborate to identify and accelerate innovative drug candidates for the treatment and prevention of diseases with high unmet medical needs. Read more...

TOPICS:

Pfizer Reports Top Line Results from Phase 3 Study of Pristiq

June 15, 2015 8:22 am | News | Comments

The drug was evaluated for the efficacy, safety, and tolerability in pediatric patients ages 7 to 17 with Major Depressive Disorder. Read more...

TOPICS:

Poisonous Booze Kills Dozens in Nigeria

June 15, 2015 8:21 am | by Seth Augenstein, Digital Reporter | News | Comments

Homemade gin has killed 68 people in less than two weeks in Nigeria, prompting a government crackdown to stop its distillation, according to reports. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading